← Back to your selection

Oxford Science Enterprises

Activity from announced rounds

Activity in this selectionnrw-venture-f5757e51
Rounds participated in
2
Confirmed lead rounds
1
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$42M
2 disclosed · full round size, not this investor’s share

By stage

Seed1
Series A1

By primary sector

Climate tech1
Healthtech1

By country

United Kingdom1
United States1

Rounds

2 in this selection
ReEmerge, Inc.

ReEmerge is developing Cognitive Network Restoration Therapy (CNRT) for people with chronic cognitive impairment after brain injury. The treatment targets underactive but viable neural circuits in the central thalamus to restore function across disrupted brain networks; the company is advancing this restorative approach through clinical development.

$37MSeries A
Participant
MCatalysis

MCatalysis develops modular microwave-driven catalytic refining systems that convert distributed hydrocarbon feedstocks, including waste carbon, into drop-in liquid fuels and chemical products for industrial buyers.

$5MSeed
Lead